MantaBio

Boisfontaine pointed out that Manta Biosystems, Inc., a company headquartered in Beverly, Massachusetts, was founded in 2025 and is developing a real-time PCR platform called MantaVision. The MantaVision® system is a fully automated sample-to-answer PCR platform for rapid microbial detection. Initially, the system focused on bacterial diagnostics for companion animals, but interest from biopharmaceutical leaders conducting feasibility studies quickly revealed a greater demand: biologics production.